Accenture wraps up Octagon buyout; NextBio aids cancer researchers;

> NextBio, a provider of bioinformatics for genomics researchers, has inked a partnership with Emory University and its Winship Cancer Institute focused on hunting for biomarkers and treatments for multiple myeloma. Release

> Accenture, the global consulting and tech services giant, says it has completed its acquisition of clinical and regulatory technology provider Octagon Research Solutions. Article

> Molplex, a Newcastle, U.K., life sciences company that uses predictive chemistry software as part of its drug discovery services, has won £350,000 ($565,075) from the North West Fund. Article

> Virtify, a provider of content management software for life sciences, and Forte Research Systems, which offers a clinical research management system, plan to integrate their software. Release

> Quintiles, the CRO giant, has added interactive, role-based navigation as a new twist to its Infosario reporting and analytics platform. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.